daunorubicin has been researched along with navitoclax in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XY; Duan, YJ; Liu, C; Wu, WQ; Zhang, YC; Zheng, JR; Zhu, XF | 1 |
1 other study(ies) available for daunorubicin and navitoclax
| Article | Year |
|---|---|
[Navitoclax Combined with Daunorubicin Promotes Apoptosis of Erythroleukemia Cell Lines K562, HEL and TF-1].
Topics: Aniline Compounds; Apoptosis; Daunorubicin; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Sulfonamides | 2020 |